Elizabeth Burtally's blog posts
Bloodwise researchers present exciting new research at European meeting
The European Hematology Association meeting took place at the end of June, and many of our Bloodwise researchers were there. Find out what they and others had to say.
New approach to treating anaemia in blood cancer
Researchers have found that when mistakes happen in a gene responsible for translating DNA to protein, it can lead to the development of a type of blood cancer called myelodysplastic syndrome (MDS). Find out more about this exciting research here.
Changing patient outlook for the most common type of acute myeloid leukaemia
Our Director of Research – Dr Alasdair Rankin – talks about how doctors are using a simple blood test that is already improving the lives of patients with a particular type of acute myeloid leukaemia (AML), thanks to research funded by Bloodwise supporters.
Our Trials Acceleration Programme – fast-tracking clinical benefits to patients
If we think a drug could save lives, we want to be able to test as quickly as possible whether it’s safe and works better than current treatments. Find out how our Trials Acceleration Programme is helping us achieve this.
RUNX genes and their role in blood cancer development
Professor James Neil – one of our researchers at The University of Glasgow – sheds light on how we may be able to reverse resistance to commonly used drugs in blood cancer treatment.